Novartis AG (NVS)
NYSE • Healthcare
January 21, 2026 at 19:17 UTC
Name
CEO
Website
Industry
Year Founded
Employees
Novartis AG is a pharmaceutical company that discovers, develops, and supplies medicines for conditions managed in specialty and primary care. Its model connects research with manufacturing and patient access so new therapies move from trials to practice under consistent standards. Programs focus on areas where evidence, careful dosing, and long follow-up matter, which is why labeling clarity and clinician education sit alongside science as core work. Supply chains and quality systems are organized for continuity rather than spectacle, keeping availability steady once treatment becomes part of care. Country teams adapt to local frameworks while holding to shared safety principles. Within the healthcare sector, Novartis acts as a long-horizon manufacturer and science organization, turning complex research into options that clinicians can use predictably in hospitals and clinics around the world.
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Novartis AG's Technical Indicators Summary
NVS is exhibiting a bullish trend supported by a strong ADX reading near 30, indicating solid trend strength. Momentum remains positive as reflected by the MACD and CCI, while the RSI suggests the stock is nearing overbought levels but still holding steady. Price action is comfortably above key moving averages, including the 200-day, reinforcing underlying strength. Although volatility appears moderate with the ATR signaling stability, volume confirms buying interest through a rising On-Balance Volume. Despite some caution from shorter-term oscillators signaling potential pullbacks, the overall technical picture favors sustained upward momentum. The technical takeaway is that NVS maintains a robust bullish stance with healthy trend and momentum indicators.
| Indicator | Value |
|---|---|
RSI (14) | 66.89 |
Stochastic %K (14, 3, 3) | 83.33 |
CCI (20) | 111.84 |
WPR (14) | -18.61 |
Momentum (10) | 5.80 |
MFI | 52.15 |
MACD Level (12, 26) | 2.82 |
Bollinger Bands | $134.48 - $145.71 |
ATR (14) | $2.36 (1.63%) |
ADX (14) | 29.66 |
OBV | 53,257,400 |
Simple Moving Averages | $123.15 - $142.22(5 indicators) |
Exponential Moving Averages | $123.84 - $142.29(5 indicators) |
Get premium market insights delivered directly to your inbox.
NVS opened firmer and now trades 0.383% above yesterday’s close at 144.13. Sector performance is mildly positive at 1.05%, providing a small boost to sentiment. NVS opens firmer, buoyed by sector growth and news on carcinoid tumor market expansion.
Price Change
from $143.58 close
+$0.55
Trading Volume
Below avg (1.8M)
1M
vs S&P 500 Today
Moderate Outperformance
+0.36%
52-Week Position
Near highs
95.4%
Updated: January 21, 2026 at 17:32 UTC
How Recent Rallies Stack Up Against Valuations
January 11, 2026